Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
AlphaVax, Inc. Snapshot 5
AlphaVax, Inc. Overview 5
Key Information 5
Key Facts 5
AlphaVax, Inc. – Research and Development Overview 6
Key Therapeutic Areas 6
AlphaVax, Inc. – Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products – Monotherapy 10
AlphaVax, Inc. – Pipeline Products Glance 11
AlphaVax, Inc. Clinical Stage Pipeline Products 11
Phase I Products/Combination Treatment Modalities 11
AlphaVax, Inc. – Early Stage Pipeline Products 12
Pre-Clinical Products/Combination Treatment Modalities 12
AlphaVax, Inc. – Drug Profiles 13
AVX101 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
AVX502 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
AVX701 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Botulinum Toxin Vaccine 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Equine Encephalitis Vaccine 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Filovirus Vaccines 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
HER2 Vaccine 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
HSV-2 Vaccine 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Multivalent HIV Vaccine 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
RSV Vaccine 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
SARS Vaccine 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Smallpox Vaccine 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
TRP-2 Vaccine 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Vaccine for Pandemic Influenza (H1 & H5) 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
AlphaVax, Inc. – Pipeline Analysis 28
AlphaVax, Inc. – Pipeline Products by Therapeutic Class 28
AlphaVax, Inc. – Pipeline Products By Target 29
AlphaVax, Inc. – Pipeline Products by Route of Administration 30
AlphaVax, Inc. – Recent Pipeline Updates 31
AlphaVax, Inc. – Locations And Subsidiaries 32
Head Office 32
AlphaVax, Inc., Recent Developments 33
AlphaVax, Inc.- Press Release 33
Nov 04, 2009: AlphaVax Progresses A Prophylactic HSV Vaccine 33
Sep 01, 2009: AlphaVax Progresses H1N1 Influenza Vaccine 33
Aug 31, 2009: AlphaVax Advances Filovirus Biodefense Vaccines 33
Jul 17, 2009: Alphavax Announces Results From Initial Testing OF Its H1N1 (Swine) Influenza Vaccine 34
Financial Deals Landscape 35
AlphaVax, Inc., Deals Summary 35
AlphaVax, Inc., Pharmaceuticals & Healthcare, Deal Details 36
Venture Financing 36
AlphaVax Secures $12.7 Million In Series E Funding 36
Licensing Agreements 37
AlphaVax Extends Its Licensing Agreement With Wyeth 37
Novartis Enters Into Licensing Agreement With AlphaVax 38
Appendix 40
Methodology 40
Coverage 40
Secondary Research 40
Primary Research 40
Expert Panel Validation 40
Contact Us 41
Disclaimer 41
List of Tables
AlphaVax, Inc., Key Information 5
AlphaVax, Inc., Key Facts 5
AlphaVax, Inc. – Pipeline by Indication, 2012 8
AlphaVax, Inc. – Pipeline by Stage of Development, 2012 9
AlphaVax, Inc. – Monotherapy Products in Pipeline, 2012 10
AlphaVax, Inc. – Phase I, 2012 11
AlphaVax, Inc. – Pre-Clinical, 2012 12
AlphaVax, Inc. – Pipeline By Therapeutic Class, 2012 28
AlphaVax, Inc. - Pipeline By Target, 2012 29
AlphaVax, Inc. – Pipeline By Route of Administration, 2012 30
AlphaVax, Inc. – Recent Pipeline Updates, 2012 31
AlphaVax, Inc., Deals Summary 35
AlphaVax Secures $12.7 Million In Series E Funding 36
AlphaVax Extends Its Licensing Agreement With Wyeth 37
Novartis Enters Into Licensing Agreement With AlphaVax 38
List of Figures
AlphaVax, Inc. – Pipeline by Indication, 2012 7
AlphaVax, Inc. – Pipeline by Stage of Development, 2012 9
AlphaVax, Inc. – Monotherapy Products in Pipeline, 2012 10
AlphaVax, Inc. – Pipeline By Therapeutic Class, 2012 28
AlphaVax, Inc. – Pipeline By Route of Administration, 2012 30